Clinimark Acquired by Element Materials Technology

KO client Clinimark, a global leader for clinical FDA validation testing of vital sign data for medical and home health devices, has been acquired by Element Materials Technology.

The KO team, led by attorney Ryan Sykora, partner John Gaddis, attorney Logan DeSouza and corporate paralegal Sara Shelly, represented Clinimark in this transaction.

Clinimark is the world leading expert in the clinical validation of pulse oximetry testing and blood pressure measurement, and also supports validation testing of respiratory rate, heart function and sleep apnea. Their services and technology have been incorporated into consumer electronics and wearables, digital health and home health and wellness platforms.

Element is one of the world’s leading global providers of testing, inspection and certification services for a diverse range of products, materials and technologies in advanced industrial supply chains. This acquisition will help Element to continue to expand its life sciences work.

“The acquisition of Clinimark gives us the opportunity to broaden our support to connected technologies and life sciences customers throughout the value chain, while giving us exposure to the clinical testing side of the medical device world,” said Rick Sluiters, Executive Vice President Americas at Element. “Life sciences is now the largest end-market we serve at Element, and the acquisition of Clinimark further strengthens our position and the breadth of our service provision to customers.”